XoMotion™ logo

XoMotion™

Paid

Hands-free, upright mobility — for how people really move!

5.0
Type
Saas
Company
Human In Motion Robotics

About XoMotion™

XoMotion™ is a next-generation self-balancing exoskeleton platform developed by Human In Motion Robotics (HMR) for individuals with lower extremity motor deficits. It is designed to mimic the physiological motion of the lower extremity, enabling complex walking motions and providing superior postural control. The device features advanced sensor systems and multi-modal controllers that allow hands-free functionality, offering unprecedented freedom and independence. XoMotion™ is not yet cleared by the FDA. The platform has three development stages: Ambulatory Training (XoMotion-R) for spinal cord injury patients available at rehabilitation centers in early 2025; Therapeutic Recovery for stroke and other neurological conditions (future); and Personal Mobility for daily use at home and in the community (future). The system accommodates users from 5'0" to 6'4" in height and up to 220 lbs, includes hot-swappable batteries for continuous use, and offers a flexible open control system for research investigators.

Key Features

Self-balancing, hands-free functionality
Mimics physiological motion of the lower extremity
Advanced sensor systems and multi-modal controllers
Complex walking motions and superior postural control
Hot-swappable battery for continuous use
Accommodates 5'0" to 6'4" height and up to 220 lbs weight
Easily adjustable between subjects
Flexible open control system for research investigators
Provides access to kinematic, activity, and sensor-based data

Pros & Cons

Pros
  • Self-balancing design enables hands-free use and natural motion
  • Mimics physiological lower extremity motion for complex walking tasks
  • Superior postural control enhances stability and safety
  • Easily adjustable to accommodate a wide range of patient heights and weights
  • Hot-swappable battery allows extended continuous use
  • Open control platform supports novel research and validation
Cons
  • Not yet cleared by the FDA, limiting availability
  • Current ambulatory training version (XoMotion-R) only available at rehab centers in early 2025
  • Therapeutic and personal mobility versions are future products with no release date
  • Maximum user weight limited to 220 lbs
  • Pricing not publicly available (contact required)

Best For

Ambulatory training for spinal cord injury patientsTherapeutic recovery for stroke and other neurological conditions (future)Personal mobility for daily use at home and in the community (future)Research collaboration for academic, clinical, or robotics investigatorsClinical trial participation for patients with mobility impairments

Alternatives to XoMotion™

FAQ

Is XoMotion cleared by the FDA?
No, XoMotion is not yet cleared by the FDA.
When will XoMotion be available?
XoMotion-R for ambulatory training will be available at rehabilitation centers in early 2025. Future versions for therapeutic recovery and personal mobility are planned but not yet released.
Who can use XoMotion?
XoMotion is designed for individuals with lower extremity motor deficits. Initially it is intended for ambulatory training with spinal cord injury patients.
What are the physical specifications of XoMotion?
XoMotion accommodates users from 5'0" to 6'4" in height and up to 220 lbs in weight. It is easily adjustable and includes a hot-swappable battery.
How can I participate in clinical trials with XoMotion?
You can contact Human In Motion Robotics through their website to learn about ongoing clinical trials at partner sites.